Michele Cottler‐Fox

A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1

John D. Shaughnessy, Fenghuang Zhan, Bart Burington et al. · Blood · 2006 · 904 citations

Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation

Michele Cottler‐Fox, J. O’Shaughnessy, S Doren et al. · Blood · 1995 · 478 citations

Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3

Bart Barlogie, Elias Anaissie, Frits van Rhee et al. · British Journal of Haematology · 2007 · 325 citations · Full text

CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies

Dimitriοs Mavroudis, E.J. Read, Michele Cottler‐Fox et al. · Blood · 1996 · 243 citations · Full text

Infusion of haplo‐identical killer immunoglobulin‐like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation

Jumei Shi, Guido Tricot, Susann Szmania et al. · British Journal of Haematology · 2008 · 191 citations · Full text

Cell Therapy, Transplantation, Marrow Transplantation +14